Did you know…
VTE Risk Assessment in all English hospitals. After much campaigning, risk assessment was mandated and adverse VTE events have fallen.
In the latest NHS England data released this week the national VTE prevention programme in England shows a benefit of systematic VTE prevention driven by mandatory risk assessment.
The NHS Digital national VTE indicator shows a >20% reduction in adverse outcomes!
Avoidable events are being prevented and lives are being saved - this approach requires worldwide adoption. #PreventProtectInform
Full VTE-related costs to the NHS are difficult to extract and can go undocumented, but in the APPG for Thrombosis, annual report 2016/17, a survey of English CCGs asked what their recorded costs for VTE treatment, hospital bed days, sanctions and litigation, for 2016/17.
Of the 22% of CCGs providing figures, the average annual cost for 2016/17 was £938,357 per CCG
(range spread from £63,358 South Lincolnshire to £7million in the Cambridge and Peterborough CCG area)
If this figure was to be averaged across all 211 CCGs in England this would be a cost to NHS services of £197,993,327
In Scotland, a 2018 freedom of information (FOI) in 2018 evidenced that between 2008 - 2017: 75,846 people were admitted to hospital for VTE in Scotland between 2008-2017
Over the same period, admissions with a diagnosis of VTE rose from 6,624 to 8,371
13,961 people died from a VTE episode in Scotland between 2008-2017
The number of patients dying of VTE in Scotland had increased by 1/3 between 2008-2017
70% of NHS Health Boards recorded more VTE-related deaths in 2017 than 2008
70% NHS Health Boards recorded increased VTE incidence in (2017 – 2008)
The cost of DVT and PE to NHS Scotland:
Ref: FOI Dec 2018 National Services Scotland (Information Services Division)